Docket Room.
H 2404·MA·house

An Act relative to increased availability of opioid antagonist medication

FailedFiled Feb 27, 2025
Sponsor: Kate Donaghue
Latest Action

House: Accompanied a study order, see H5234

Mar 16, 2026

Email me when H 2404 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track H 2404. By continuing you agree to the Terms and Privacy Policy.

Summary

The bill directs the department to issue regulations that require every Commonwealth agency and board to keep opioid‑antagonist medication on hand and to train their employees on its use each year. It also asks the department to provide non‑mandatory guidance to private employers on acquiring the medication and conducting annual training. The purpose is to broaden access to life‑saving overdose‑reversal drugs.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about H 2404

3 free questions a day, no account

History

  1. Accompanied a study order, see H5234
  2. Reporting date extended to Thursday, October 9, 2025
  3. Hearing scheduled for 06/11/2025 from 01:00 PM-05:00 PM in A-1
  4. Senate concurred
  5. Referred to the committee on Public Health

Sponsors

  • Kate Donaghue · sponsor
  • Angelo J. Puppolo, Jr.
  • Carmine Lawrence Gentile
  • Kristin E. Kassner
  • Vanna Howard

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when H 2404 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track H 2404 free

Or ask your AI assistant about H 2404 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice